Antiretroviral Treatment Long-Term (ALT) Cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda

dc.contributor.author	Castelnuovo, Barbara
dc.contributor.author	Mubiru, Frank
dc.contributor.author	Kiragga, Agnes N.
dc.contributor.author	Musomba, Rachel
dc.contributor.author	Mbabazi, Olive
dc.contributor.author	Gonza, Paul
dc.contributor.author	Kambugu, Andrew
dc.contributor.author	Ratanshi, Rosalind Parks
dc.date.accessioned	2022-03-20T21:38:52Z
dc.date.available	2022-03-20T21:38:52Z
dc.date.issued	2018
dc.identifier.citation	Castelnuovo, B., Mubiru, F., Kiragga, A. N., Musomba, R., Mbabazi, O., Gonza, P., ... & Ratanshi, R. P. (2018). Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda. BMJ open, 8(2), e015490.http://dx.doi.org/10.1136/bmjopen-2016-015490	en_US
dc.identifier.uri	https://nru.uncst.go.ug/xmlui/handle/123456789/2841
dc.description.abstract	Little information is available on patients on antiretroviral treatment (ART) after a long-term period from sub-Saharan Africa, with the longest follow-up and related outcomes being after 10 years on ART. At the Infectious Diseases Institute (IDI) (Kampala, Uganda), we set up a cohort of patients already on ART for 10 years at the time of enrolment, who will be followed up for additional 10 years.	en_US
dc.language.iso	en	en_US
dc.publisher	BMJ open	en_US
dc.title	Antiretroviral Treatment Long-Term (ALT) Cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda	en_US
dc.type	Article	en_US